創源股份(300703.SZ):擬使用1000萬元與北京行律投資合作參設股權投資基金
格隆匯5月17日丨創源股份(300703.SZ)公佈,公司於2021年5月17日召開第三屆董事會第六會議審議通過《關於與專業投資機構合作投資設立基金的議案》,為藉助專業機構的專業力量及資源優勢,進一步擴寬公司行業領域及提升競爭力,同意公司作為有限合夥人使用自有資金1000萬元與北京行律投資管理有限公司合作參與設立青島行律用奇股權投資合夥企業(有限合夥)(暫定名)股權投資基金。投資方向:主要用於投資智能製造、消費、大健康等潛力行業領域的成長型企業。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.